Mr. Andreas Dotterweich reports

AURORA LAUNCHES NEW EUROPEAN WEBSITES, SHOWCASING SCIENCE-BACKED CANNABIS LEADERSHIP

Aurora Cannabis Inc. has launched four brand new websites to support key European markets, continuing its investment in the region through a more focused, locally relevant digital presence. The refreshed platforms are designed to better reflect Aurora's science-backed approach, manufacturing expertise and brand strength, while improving engagement with health care professionals, partners and prospective employees across Europe. The central European site (Aurora Medicine) provides easy access to the dedicated regional sites for Germany, the United Kingdom and Poland.

"Our new European websites are a demonstration of our ongoing investment and long-term commitment to Aurora's fastest-growing region," says Andreas Dotterweich, senior vice-president, Aurora Europe. "The sites leverage our global leadership in medical cannabis, putting our products, scientific expertise and partnerships front and centre, providing enhanced resources for health care practitioners and partners looking for a trusted resource. This streamlined digital presence across Europe positions Aurora to drive growth, reinforce our leadership and deliver lasting value in Europe."

Building on the recent evolution of Aurora's global brand identity, the new regional websites showcase manufacturing excellence, highlighting both Canadian-made and local production through updated videos and photos while emphasizing quality, compliance and evidence-based processes. Each platform is available in the native language of its market, and all regional sites are seamlessly accessible from the drop-down menu on the central European hub.

The new websites enhance the experience for health care practitioners and partners across Europe. Aligned with Aurora's broader European communications strategy, they establish a locally relevant platform that strengthens engagement, showcases the company's leadership and positions Aurora to capture emerging opportunities in the evolving medical cannabis market.

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora's portfolio of trusted, leading brands includes Aurora, MedReleaf, Pedanios, IndiMed, San Raf, Tasty's and Whistler Cannabis Co. The company also holds a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. With world-class good-manufacturing-practice-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of opening the world to cannabis.

We seek Safe Harbor.